| 14th week of 2021 patent applcation highlights part 18 |
| Patent application number | Title | Published |
|---|
| 20210101862 | DIAMINE COMPOUND, METHOD OF PREPARING DIAMINE COMPOUND, AND POLYIMIDE | 2021-04-08 |
| 20210101863 | Substituted Phenethylamines with Serotoninergic and/or Norepinephrinergic Activity | 2021-04-08 |
| 20210101864 | ORGANIC COMPOUND, ORGANIC LIGHT-EMITTING ELEMENT, DISPLAY APPARATUS, IMAGE PICKUP APPARATUS, LIGHTING APPARATUS, AND MOVING OBJECT | 2021-04-08 |
| 20210101865 | METHOD FOR PRODUCING METHIONINE | 2021-04-08 |
| 20210101866 | PROCESS FOR THE PREPARATION OF ELAFIBRANOR AND NOVEL SYNTHESIS INTERMEDIATES | 2021-04-08 |
| 20210101867 | POLYMERIC MATERIALS FORMED USING INITIATORS WITH A KETONE GROUP AND TWO THIOCARBONYLTHIO-CONTAINING GROUPS | 2021-04-08 |
| 20210101868 | Substituted 3-Dialkylaminomethyl-Piperidin-4-yl-Benzamides and Methods of Making and Using Same | 2021-04-08 |
| 20210101869 | IONIC COMPOUNDS COMPRISING 1,3-DIALKYL-4,5,6,7-TETRAHYDRO-1H-BENZO[D]IMIDAZOL-3-IUM CATIONS FOR USE IN COATINGS AND ADHESIVES | 2021-04-08 |
| 20210101870 | 2,5-DISUBSTITUTED 3-METHYL PYRAZINES AND 2,5,6-TRISUBSTITUTED 3-METHYL PYRAZINES AS ALLOSTERIC SHP2 INHIBITORS | 2021-04-08 |
| 20210101871 | SELECTIVE SULFONATION OF BENZODIAZEPINE DERIVATIVES | 2021-04-08 |
| 20210101872 | C-ABL TYROSINE KINASE INHIBITORY COMPOUND EMBODIMENTS AND METHODS OF MAKING AND USING THE SAME | 2021-04-08 |
| 20210101873 | FORMULATION OF METAXALONE | 2021-04-08 |
| 20210101874 | MICROBIOCIDAL OXADIAZOLE DERIVATIVES | 2021-04-08 |
| 20210101875 | AMINOALCOHOL LIPIDOIDS AND USES THEREOF | 2021-04-08 |
| 20210101876 | HYDROPHOBIC PALLADIUM/METAL ORGANIC FRAMEWORK MATERIAL, PREPARATION METHOD THEREOF, AND APPLICATION THEREFOR FOR USE IN SYNTHESIZING 2,5-DIMETHYLFURAN | 2021-04-08 |
| 20210101877 | ANTI-INFECTIVE AGENTS | 2021-04-08 |
| 20210101878 | Cannabinergic Compounds And Uses Thereof | 2021-04-08 |
| 20210101879 | AMYLOID PROTEIN-SELECTIVE BACE INHIBITORS (ASBIs) FOR ALZHEIMER?S DISEASE | 2021-04-08 |
| 20210101880 | AZOLOPYRIMIDINE FOR THE TREATMENT OF CANCER-RELATED DISORDERS | 2021-04-08 |
| 20210101881 | PYRIMIDINE COMPOUND, PREPARATION METHOD THEREOF AND MEDICAL USE THEREOF | 2021-04-08 |
| 20210101882 | FLUORINE-SUBSTITUTED INDAZOLE COMPOUNDS AND USES THEREOF | 2021-04-08 |
| 20210101883 | ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME | 2021-04-08 |
| 20210101884 | COMPOSITIONS AND METHODS FOR PREPARING AND USING AZETIDINES | 2021-04-08 |
| 20210101885 | PROCESSES FOR THE PREPARATION OF PYRAZOLE DERIVATIVES USEFUL AS MODULATORS OF THE 5-HT2A SEROTONIN RECEPTOR | 2021-04-08 |
| 20210101886 | IL-17A MODULATORS AND USES THEREOF | 2021-04-08 |
| 20210101887 | ISOINDOLINONE INHIBITORS OF THE MDM2-P53 INTERACTION AND PROCESS FOR MAKING THEM | 2021-04-08 |
| 20210101888 | SPLICING MODULATOR ANTIBODY-DRUG CONJUGATES AND METHODS OF USE | 2021-04-08 |
| 20210101889 | 6-PYRIMIDIN-ISOINDOLE DERIVATIVE AS ERK1/2 INHIBITOR | 2021-04-08 |
| 20210101890 | 2-OXINDOLE COMPOUNDS | 2021-04-08 |
| 20210101891 | HISTONE ACETYLTRANSFERASE (HAT) INHIBITOR AND USE THEREOF | 2021-04-08 |
| 20210101892 | BICYCLIC COMPOUND AND USE THEREOF | 2021-04-08 |
| 20210101893 | PHARMACEUTICAL COMPOUNDS | 2021-04-08 |
| 20210101894 | BACE1 INHIBITORS | 2021-04-08 |
| 20210101895 | LIVER X RECEPTOR (LXR) MODULATORS FOR THE TREATMENT OF DERMAL DISEASES, DISORDERS AND CONDITIONS | 2021-04-08 |
| 20210101896 | MONOCYCLIC COMPOUNDS USEFUL AS GPR120 MODULATORS | 2021-04-08 |
| 20210101897 | PROCESS FOR THE SYNTHESIS OF 2-[(2S)-1-AZABICYCLO[2.2.2]OCT-2-YL]-6-(3-METHYL-1H-PYRAZOL-4-YL)THIENO[3- ,2-d]PYRIMIDIN-4(3H)-ONE | 2021-04-08 |
| 20210101898 | AMIDE SUBSTITUTED IMIDAZO[4,5-C]QUINOLINE COMPOUNDS WITH A BRANCHED CHAIN LINKING GROUP FOR USE AS AN IMMUNE RESPONSE MODIFIER | 2021-04-08 |
| 20210101899 | INHIBITORS OF MUTANT ISOCITRATE DEHYDROGENASES AND COMPOSITIONS AND METHODS THEREOF | 2021-04-08 |
| 20210101900 | EMETINE AURISTATIN COMPOUNDS | 2021-04-08 |
| 20210101901 | PREPARATION OF PYRAZOLO[3,4-B]PYRIDINES AS ANTIMALARIALS | 2021-04-08 |
| 20210101902 | COMPOUNDS AND COMPOSITIONS AS INHIBITORS OF ENDOSOMAL TOLL-LIKE RECEPTORS | 2021-04-08 |
| 20210101903 | NOVEL COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF FOR THE TREATMENT OF DISEASES | 2021-04-08 |
| 20210101904 | PRC2 INHIBITORS | 2021-04-08 |
| 20210101905 | Development of Imaging and Therapeutic Glucose Analogues for Sodium Dependent Glucose Transporters | 2021-04-08 |
| 20210101906 | BIOACTIVE CONJUGATE, PREPARATION METHOD THEREFOR AND USE THEREOF | 2021-04-08 |
| 20210101907 | NOVEL ANTIMALARIAL COMPOUNDS, PROCESS FOR PREPARATION AND THEIR USE FOR DRUG RESISTANT MALARIA | 2021-04-08 |
| 20210101908 | SUBSTITUTED INHIBITORS OF MENIN-MLL AND METHODS OF USE | 2021-04-08 |
| 20210101909 | PREPARATION OF CONDENSED TRIAZEPINE DERIVATIVES AND THEIR USE AS BET INHIBITORS | 2021-04-08 |
| 20210101910 | INHIBITORS OF BRUTON'S TYROSINE KINASE AND METHODS OF THEIR USE | 2021-04-08 |
| 20210101911 | BENZOXAZINONE COMPOUNDS AS KLK5/7 DUAL INHIBITORS | 2021-04-08 |
| 20210101912 | NEW SPIRO[3H-INDOLE-3,2'-PYRROLIDIN]-2(1H)-ONE COMPOUNDS AND DERIVATIVES AS MDM2-P53 INHIBITORS | 2021-04-08 |
| 20210101913 | 2-OXOTHIATOLE COMPOUNDS HAVING ACTIVITY AS CPLA2 INHIBITORS FOR THE TREATMENT OF INFLAMMATORY DISORDERS AND HYPERPROLIFERATIVE DISORDERS | 2021-04-08 |
| 20210101914 | METHOD TO MAKE SCALABLE ULTRATHIN HEXAGONALLY FACETED METAL-ORGANIC FRAMEWORK (MOF) AND METHOD OF USING SAME FOR DETECTING EXPLOSIVES AND OTHER NITRO-AROMATIC COMPOUNDS | 2021-04-08 |
| 20210101915 | NEAR-IR GLUCOSE SENSORS | 2021-04-08 |
| 20210101916 | OXABOROLE ESTERS AND USES THEREOF | 2021-04-08 |
| 20210101917 | TRIIODOSILYLAMINE PRECURSOR COMPOUNDS | 2021-04-08 |
| 20210101918 | 1,1,1-TRIS(ORGANOAMINO)DISILANE COMPOUNDS AND METHOD OF PREPARING SAME | 2021-04-08 |
| 20210101919 | PHOSPHOLIPID CONCENTRATE MANUFACTURING METHOD | 2021-04-08 |
| 20210101920 | BISPHOSPHONATE QUINOLONE CONJUGATES AND USES THEREOF | 2021-04-08 |
| 20210101921 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | 2021-04-08 |
| 20210101922 | NOVEL RUTHENIUM COMPLEXES AND THEIR USE IN OLEFIN METATHESIS REACTIONS | 2021-04-08 |
| 20210101923 | NUCLEIC ACID PRODRUGS | 2021-04-08 |
| 20210101924 | CYCLIC DINUCLEOTIDE COMPOUNDS AS STING AGONISTS | 2021-04-08 |
| 20210101925 | OXYSTEROLS AND METHODS OF USE THEREOF | 2021-04-08 |
| 20210101926 | SYNTHESIS OF GLYCOCONJUGATE DERIVATIVES OF A BILE ACID | 2021-04-08 |
| 20210101927 | 3-DESOXY DERIVATIVE AND PHARMACEUTICAL COMPOSITIONS THEREOF | 2021-04-08 |
| 20210101928 | COMPOSITIONS AND METHODS FOR TREATING CNS DISORDERS | 2021-04-08 |
| 20210101929 | METHOD FOR STABILIZING PROTEIN COMPRISING FORMULATIONS BY USING A MEGLUMINE SALT | 2021-04-08 |
| 20210101930 | METHODS OF GENERATING NANOARRAYS AND MICROARRAYS | 2021-04-08 |
| 20210101931 | Methods and compositions useful for inhibiting growth of certain bacteria | 2021-04-08 |
| 20210101932 | BICYCLIC PEPTIDE LIGANDS SPECIFIC FOR PD-L1 | 2021-04-08 |
| 20210101933 | MULTIMERIC BICYCLIC PEPTIDE LIGANDS | 2021-04-08 |
| 20210101934 | COMPOUNDS AND METHODS FOR TREATING PAIN | 2021-04-08 |
| 20210101935 | CYCLIC PEPTIDOMIMETIC FOR THE TREATMENT OF NEUROLOGICAL DISORDERS | 2021-04-08 |
| 20210101936 | CYCLIC PEPTIDES AS PROTEIN TARGETING AGENTS | 2021-04-08 |
| 20210101937 | HETEROTANDEM BICYCLIC PEPTIDE COMPLEXES | 2021-04-08 |
| 20210101938 | MECP2 BASED THERAPY | 2021-04-08 |
| 20210101939 | MODIFIED ANTIMICROBIAL PEPTIDE DERIVED FROM AN ARGININE-RICH DOMAIN | 2021-04-08 |
| 20210101940 | Stabilized Soluble Pre-Fusion RSV F Polypeptides | 2021-04-08 |
| 20210101941 | CYCLIC PEPTIDES FOR PROTECTION AGAINST RESPIRATORY SYNCYTIAL VIRUS | 2021-04-08 |
| 20210101942 | FACTOR H BINDING PROTEIN VARIANTS AND METHODS OF USE THEREOF | 2021-04-08 |
| 20210101943 | NEISSERIA MENINGITIDIS COMPOSITIONS AND METHODS THEREOF | 2021-04-08 |
| 20210101944 | FUSION PROTEIN CONTAINING TRAIL AND IGG BINDING DOMAIN AND THE USES THEREOF | 2021-04-08 |
| 20210101945 | Polypeptides Capable of Forming Homo-Oligomers with Modular Hydrogen Bond Network-Mediated Specificity and Their Design | 2021-04-08 |
| 20210101946 | HIGH MOLECULAR WEIGHT SILK FIBROIN AND USES THEREOF | 2021-04-08 |
| 20210101947 | METHODS AND USES OF MODULATORS OF ANAPHASE PROMOTING COMPLEX (APC) ACTIVITY FOR TREATING CANCER | 2021-04-08 |
| 20210101948 | TAU PEPTIDE IMMUNOGEN CONSTRUCTS | 2021-04-08 |
| 20210101949 | PEPTIDES OF BROMODOMAIN TESTIS-SPECIFIC PROTEIN (BRDT) | 2021-04-08 |
| 20210101950 | METHOD FOR IN VITRO GLYCOENGINEERING OF AN ERYTHROPOIESIS STIMULATING PROTEIN | 2021-04-08 |
| 20210101951 | GDF11 VARIANTS AND USES THEREOF | 2021-04-08 |
| 20210101952 | Engineered Optimized Cytokine Compositions | 2021-04-08 |
| 20210101953 | Human Interleukin-2 and Anti-human Epithelial Cell Adhesion Molecule Single-Chain Antibody Fusion Protein and Application Thereof | 2021-04-08 |
| 20210101954 | CHIMERIC ANTIBODY/T-CELL RECEPTOR CONSTRUCTS AND USES THEREOF | 2021-04-08 |
| 20210101955 | ISOLATED T CELL RECEPTORS AND METHODS OF USE THEREFOR | 2021-04-08 |
| 20210101956 | TRANSFECTED T-CELLS AND T-CELL RECEPTORS FOR USE IN IMMUNOTHERAPY AGAINST CANCERS | 2021-04-08 |
| 20210101957 | NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST OVARIAN CANCER AND OTHER CANCERS | 2021-04-08 |
| 20210101958 | NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST OVARIAN CANCER AND OTHER CANCERS | 2021-04-08 |
| 20210101959 | CHIMERIC ANTIGEN RECEPTOR | 2021-04-08 |
| 20210101960 | G-PROTEIN-COUPLED RECEPTOR INTERNAL SENSORS | 2021-04-08 |
| 20210101961 | Polypeptides With Enhanced Anti-Inflammatory And Decreased Cytotoxic Properties And Relating Methods | 2021-04-08 |
